Neumann Advisory Hong Kong LTD Moderna, Inc. Transaction History
Neumann Advisory Hong Kong LTD
- $210 Million
- Q2 2024
A detailed history of Neumann Advisory Hong Kong LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Neumann Advisory Hong Kong LTD holds 21,285 shares of MRNA stock, worth $1.55 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
21,285
Previous 22,107
3.72%
Holding current value
$1.55 Million
Previous $2.36 Million
7.3%
% of portfolio
1.2%
Previous 1.16%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
1,112Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$3.17 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.88 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.86 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1.1 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$527 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $28.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...